TrialEuropean heart journal2026

Pelacarsen and lipoprotein(a) apheresis in secondary prevention: the Lp(a)FRONTIERS APHERESIS trial.

Klaus G Parhofer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.